Pneumatosis intestinalis associated with α-glucosidase inhibitors: a pharmacovigilance study of the FDA adverse event reporting system from 2004 to 2022
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pneumatosis intestinalis associated with α-glucosidase inhibitors: a pharmacovigilance study of the FDA adverse event reporting system from 2004 to 2022
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2023-11-06
DOI
10.1080/14740338.2023.2278708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges
- (2023) Alia Mushtaq et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis
- (2023) Tingting Zhang et al. Frontiers in Pharmacology
- Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database
- (2023) Hui Zhao et al. Frontiers in Pharmacology
- Inactivation of the antidiabetic drug acarbose by human intestinal microbial-mediated degradation
- (2023) Jinzhong Tian et al. Nature Metabolism
- Pneumatosis Intestinalis in Necrotizing Enterocolitis
- (2022) Lorraine Tong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pneumatosis Intestinalis Induced by Anticancer Treatment: A Systematic Review
- (2022) Gianluca Gazzaniga et al. Cancers
- Prednisolone induced pneumatosis coli and pneumoperitoneum
- (2022) Serene S N Goh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pneumatosis Intestinalis Induced by Alpha-Glucosidase Inhibitors in Patients with Diabetes Mellitus
- (2022) Blake J. McKinley et al. Journal of Clinical Medicine
- Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists
- (2021) Jamy Ard et al. ADVANCES IN THERAPY
- DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020
- (2021) Patrick M. Jedlowski et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source
- (2021) Yoshihiro Noguchi et al. BRIEFINGS IN BIOINFORMATICS
- Pneumatosis intestinalis causing pneumoperitoneum
- (2020) Yang-Yuan Chen et al. DIGESTIVE AND LIVER DISEASE
- Pneumatosis cystoides intestinalis and hyperganglionosis – Cause or effect? A review
- (2020) S. Tharmaradinam et al. PATHOLOGY RESEARCH AND PRACTICE
- Pneumatosis Intestinalis in COVID-19
- (2020) Seetha Lakshmanan et al. Clinical Gastroenterology and Hepatology
- Comparison of Data Mining Methods for the Signal Detection of Adverse Drug Events with a Hierarchical Structure in Postmarketing Surveillance
- (2020) Goeun Park et al. Life-Basel
- Standards of medical care for type 2 diabetes in China‐0027
- (2019) Weiping Jia et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Idiopathic pneumatosis intestinalis secondary to lactulose use in patients with cirrhosis
- (2019) Lee J Varelas et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase
- (2018) Kemin Tan et al. PROTEIN SCIENCE
- Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
- (2017) Yanyun Gu et al. Nature Communications
- Spontaneous complete resolution of pneumomediastinum and pneumatosis intestinalis caused by acute GVHD
- (2016) Fatma Keklik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Neumatosis intestinal secundaria a quimioterapia con 5-fluorouracilo
- (2016) Andrés Vargas et al. Gastroenterologia y Hepatologia
- The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomised controlled trial.
- (2015) Sony S. Thazhath et al. DIABETES
- Abdominal Distension in a Patient With Hepatocellular Carcinoma
- (2015) Ying-Hao Huang et al. GASTROENTEROLOGY
- Segmental pneumatosis cystoides coli: Computed tomography-facilitated diagnosis
- (2015) Dorota Ksiadzyna et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
- (2014) Tanja Dujic et al. DIABETES
- Imaging assessment and clinical significance of pneumatosis in adult patients
- (2014) Francesco Lassandro et al. Radiologia Medica
- Distinguishing Case Series From Cohort Studies
- (2013) Olaf M. Dekkers et al. ANNALS OF INTERNAL MEDICINE
- Pneumatosis intestinalis and perforation in Crohn's disease: Worrisome or not?
- (2013) Emilia Bareggi et al. Journal of Crohns & Colitis
- Pneumatosis cystoides intestinalis in neuropsychiatric systemic lupus erythematosus with diabetes mellitus: case report and literature review
- (2011) Yasuhiro Shimojima et al. Modern Rheumatology
- Quantitative signal detection using spontaneous ADR reporting
- (2009) A. Bate et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pneumatosis cystoides intestinalis following alpha-glucosidase inhibitor treatment: A case report and review of the literature
- (2008) Tatsuhiro Tsujimoto et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started